Procter & Gamble (NYSE:PG – Get Free Report) was upgraded by equities research analysts at Sanford C. Bernstein to a “hold” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.
PG has been the subject of a number of other research reports. UBS Group lifted their target price on Procter & Gamble from $166.00 to $172.00 and gave the stock a “buy” rating in a report on Monday, April 27th. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $165.00 to $162.00 and set an “overweight” rating for the company in a report on Friday, April 17th. Morgan Stanley decreased their target price on Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Bank of America dropped their price target on shares of Procter & Gamble from $171.00 to $167.00 and set a “buy” rating on the stock in a report on Friday, April 10th. Finally, Barclays reduced their price target on shares of Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. Eleven analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $160.78.
Read Our Latest Research Report on Procter & Gamble
Procter & Gamble Stock Up 0.8%
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm had revenue of $21.24 billion for the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter in the prior year, the firm posted $1.54 earnings per share. The business’s revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts forecast that Procter & Gamble will post 6.91 EPS for the current fiscal year.
Hedge Funds Weigh In On Procter & Gamble
A number of institutional investors have recently bought and sold shares of PG. Triodos Investment Management BV grew its holdings in Procter & Gamble by 7.3% during the 3rd quarter. Triodos Investment Management BV now owns 255,095 shares of the company’s stock valued at $39,195,000 after buying an additional 17,400 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Procter & Gamble by 0.6% in the third quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company’s stock worth $36,050,992,000 after buying an additional 1,419,322 shares in the last quarter. Gradient Investments LLC boosted its position in shares of Procter & Gamble by 12.8% during the fourth quarter. Gradient Investments LLC now owns 253,089 shares of the company’s stock worth $36,270,000 after acquiring an additional 28,777 shares during the last quarter. Fiera Capital Corp grew its stake in Procter & Gamble by 20.3% during the third quarter. Fiera Capital Corp now owns 53,128 shares of the company’s stock valued at $8,163,000 after acquiring an additional 8,961 shares in the last quarter. Finally, Arete Wealth Advisors LLC bought a new stake in Procter & Gamble in the 3rd quarter valued at $3,776,000. 65.77% of the stock is owned by institutional investors.
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
